Progressive renal disease occurs in all age groups. Congenital structural anomalies such as vesicoureteral reflux, obstruction, hypoplasia and dysplasia are the underlying causes of renal failure, especially in very young children. Chronic glomerulonephritis, focal segmental glomerulosclerosis, pyelonephritis, hemolytic uremic syndrome, immune complex diseases and hereditary nephropathies are underlying causes of renal failure in older children.
These patients have a continuous decline in renal function, which is called progression to renal failure. It is characterized by the common pathomorphological end point of tubulointerstitial fibrosis and tubular atrophy, irrespective of the underlying etiology of the renal disease. Mechanisms involved in the progression of chronic renal disease are hemodynamic changes, hypertension, degree of proteinuria, infiltration of inflammatory cells and local release of inflammatory cytokines and profibrogenic growth factors.
Processes and predictive factors of progression to renal failure are discussed here along with clinical practice guidelines: Evaluation, Classification and Stratification. Preventing the progression of renal disease is also touched upon briefly.
MORPHOLOGIC FEATURES
Loss of normal renal cells, infiltration by monocytes and/or macrophages, and interstitial fibrosis are the main morphologic features. Although there is a histological glomerular injury, the extent of tubulointerstitial injury predicts the impairment of renal function. In this context several factors play a part, such as increased synthesis and decreased breakdown of extra cellular matrix (ECM), and increased myofibroblasts . The abnormal ECM contains an excess of fibrinonectin, laminin, proteoglycans and type IV collagen and results in the impairment of cell-to-ECM interaction [1] [2] . In the process to renal progression, the balance between cell proliferation and apoptosis is also impaired. There is a loss in normal resident cell population caused by a combination of increased proapoptotic stimuli and reduced antiapoptotic stimuli. Furthermore, monocytes and macrophages are enrolled by cytokines, which are over expressed in chronic renal failure. As a response to renal injury, over expression of the macrophage colony stimulating factor by the tubules drives local macrophage proliferation in the kidney 4 . Macrophage infiltration in the interstitium correlates with the degree of renal dysfunction 5 . These cells augment the response by producing more cytokines which endorse further fibrosis and apoptosis 6 . Mast cells may also contribute to interstitial fibrosis through the association with its growth factors and myofibroblasts.
PATHOPHYSIOLOGY OF PROGRESSIVE RENAL DISEASE

Hemodynamic Factors
Decreased nephron mass followed by renal insult leads to compensatory hyperfiltration of the spared nephrons and makes it possible to maintain overall glomerular filtration rate (GFR). However, this adaptation leads to glomerular hypertension, proteinuria, and progression to renal failure. The stretching of the glomerular capillary tuft due to glomerular hypertension also stretches the neighboring mesangial cells, which induces mesangial cell proliferation followed by glomerulosclerosis 7, 8 . Early diabetic nephropathy is associated with hyperfiltration and elevated GFR. On the other hand, unilateral nephrectomy does not result in deterioration in renal function. The renal mass loss should be more than 50%, which is the critical level, and results in hyperfiltration glomerular hypertension, proteinuria and progressive renal disease 9 .
Proteinuria
Glomerular capillary hypertension and the damage to the permeability barrier result in proteinuria. Protein leaking from the glomerulus is taken up by proximal tubule cells. Proteinloaded proximal tubular cells cause activation of the intrarenal angiotensin-converting enzyme (ACE) and lead to abnormal production of endothelin-1 (ET-1), monocyte chemoattractant protein-1 (MCP-1) and RANTES (regulated on activation, normal T cell expressed and secreted) either directly or via activation of transcription factors 10, 11 . Proteinuria promotes secretion of cytokines such as transforming growth factor-β (TGF-β), tumor necrosis factor-α (TNF-α), and interleukin (IL)-4, -6, and -10. The cytokines favor fibrosis, apoptosis and monocytic infiltration, thus furthering the process.
Systemic Hypertension
Systemic hypertension is frequently present in chronic renal disease. Hypertension in chronic renal disease is multifactorial. Sodium and volume excess, activation of renin angiotensin aldosterone system, and activation of sympathic nervous system contribute to elevated blood pressure in chronic renal disease. Hypertension itself accelerates decline in renal function due to the increased glomerular capillary hypertension 12 .
Angiotensin II Angiotensin II (ANG II) is one of the key factors in progressing to renal failure. Renin splits the angiotensinogen into angiotensin I, which is converted to angiotensin II by ACE. There is now evidence that tissue-specific generation of ANG II occurs. ANG II binds to two types of receptors, AT1 and AT2, and the resulting multiple effects are mediated by these receptors (Table I) . ANG II can be produced locally in the kidney, and this local intrarenal renin-angiotensin system plays a critical role in renal autoregulation and physiologic developments 13 . The classical function of ANG II is the maintenance of extracellular volume and blood pressure during volume depletion. ANG II causes an increase in renal vascular resistance leading consequently to a decrease in renal plasma flow. Micropuncture studies have shown that ANG II preferentially raises efferent glomerular resistance. The outcome is an increase in the glomerular capillary filtration pressure, which results in a protected GFR despite an ANG II-induced decrease in renal plasma flow . In addition to its hemodynamic effects, ANG II stimulates expression of fibrinonectin, TGF-β, plasminogen activator inhibitor-1 (PAI-1), ET, aldosterone and possibly transcription factor nuclear factor κB, which all favor fibrogenesis and enrollment of macrophages 15 .
Other Chemical Mediators
Cytokines and growth factors have been shown to be involved in progression of renal disease (Table II) . Cytokines and growth factors gain 18 . Among these guidelines, definition and staging of CKD are outlined.
Guideline 1. Definition and Stages of CKD
• The presence of CKD should be established based on presence of kidney damage and level of kidney function-glomerular filtration rate (GFR), irrespective of diagnosis. Definition criteria of CKD are shown in Table III 18 . CKD is defined as either reduction in GFR below 60 ml/dk/1.73 m 2 , which represents loss of at least 50% of normal kidney function, or presence of structural or functional abnormalities of kidney with or without decreased GFR.
Among these abnormalities, proteinuria is a particularly important marker of kidney damage. Although hypertension is not included in the definition and stages of CKD, it should be noted that high blood pressure may be a presenting sign of CKD. Furthermore, patients with CKD and hypertension are at higher risk of loss of kidney function.
• The stage of disease should be assigned based on level of kidney function. Classification of CKD according to the K/DOQI is seen in Table IV . Glomerular filtration rate is a primary factor in these guidelines because it is thought that GFR provides the best measure of overall kidney function. It should be remembered that the normal levels of GFR vary according to age, gender and body size (Table V) . While GFR is lower in infancy, there is an increase in relationship to body size for up to two years, and it reaches 120-130 ml/min/1.73 m 2 in young adults 18 . For this reason, Tables III and IV apply only to children two years of age and above.
PREDICTIVE FACTORS FOR PROGRESSION OF RENAL DISEASE AND GENERAL PRINCIPLES OF TREATMENT
From the clinical point of view, progression to renal failure has a complex and multifactorial nature. Both renal and nonrenal predictive factors may take place and/or facilitate the progression to renal failure. Some of the nonrenal predisposing factors both in children and adults are genetic predisposition, low birth weight, hyperlipidemia, obesity, cardiovascular diseases, and lower economic and educational status 19 . Predictive factors of the progression to renal failure are low baseline creatinine clearance (<50 ml/min/1.73 m 2 ), Focal segmental glomerulosclerosis (FSGS) at presentation, low hematocrit, hypoalbuminemia, hypocalcemia, hyperphosphatemia and hyperparathyroidism 19 . In another study, GFR under 30ml/min and severe proteinuria were reported to be the independent predictors of progression to end stage renal failure (ESRF) in children 24 .
A successful attempt to slow down the renal progression will require a broad approach such as treatment of primary disease, aggressive treatment of hypertension and proteinuria, early referral to a nephrologist and application of potentially useful modalities (protein restriction in select patients, control of hyperphosphatemia, treatment of hyperlipidemia, erythropoietin, binding protein metabolites (Table VII) . As is the case in many public health problems, prevention of chronic renal diseases and early recognition of these diseases are more important than efforts to treat them. 
